Imaging pH with hyperpolarized 13C

NMR in Biomedicine

Volumn 24, Issue 8, 2011, Pages 1006-1015

  Gallagher, Ferdia A ^a,b   Kettunen, Mikko I ^a   Brindle, Kevin M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

13C; Bicarbonate; Dynamic nuclear polarization; Hyperpolarized carbon; MRI; PH; Pyruvate; Tumor

Indexed keywords

13C; BICARBONATE; DYNAMIC NUCLEAR POLARIZATION; HYPERPOLARIZED; PYRUVATES;

CARBON DIOXIDE; CARBONIC ANHYDRASE; CARBOXYLATION; CATALYSIS; DISEASES; ENZYME ACTIVITY; IMAGING TECHNIQUES; MAGNETIC RESONANCE IMAGING; PH; PHYSIOLOGICAL MODELS; TUMORS;

SPIN POLARIZATION;

BICARBONATE; CARBON 13; CARBON DIOXIDE; CARBONATE DEHYDRATASE; PYRUVATE DEHYDROGENASE; PYRUVIC ACID;

BODY EQUILIBRIUM; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; DECARBOXYLATION; DYNAMIC NUCLEAR POLARIZATION; HUMAN; HYPERPOLARIZATION; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; POLARIZATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BICARBONATES; CARBON DIOXIDE; CARBON ISOTOPES; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PYRUVIC ACID;

ANIMALIA; MURINAE;

EID: 80052864975     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1742     Document Type: Review

References (55)

1. White A, Handler P, Smith EL. Principles of Biochemistry. McGraw-Hill Kogakusha: New York; 1968.
2. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA. pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng. Med. Biol. Mag. 2004; 23(5): 57-64.
3. Adrogue HE, Adrogue HJ. Acid-base physiology. Respir. Care 2001; 46(4): 328-341.
4. Zhang X, Lin Y, Gillies RJ. Tumor pH and its measurement. J. Nucl. Med. 2010; 51(8): 1167-1170.
5. 11C]DMO and positron emission tomography. Ann. Neurol. 1985; 17(1): 70-79.
6. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn. Reson. Med. 2003; 50(6): 1120-1126.
7. Mayr M, Burkhalter F, Bongartz G. Nephrogenic systemic fibrosis: clinical spectrum of disease. J. Magn. Reson. Imaging, 2009; 30(6): 1289-1297.
8. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ. High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn. Reson. Med. 2006; 55(2): 309-315.
9. Beauregard DA, Parker D, Brindle KM. Relaxation-based mapping of tumour pH. Proc. Int. Soc. Magn. Reson. Med. 1998; 6: 53.
10. 2 contrast agents. NMR Biomed. 2011; DOI: 10.1002/nbm.1701.
11. Longo DL, Dastru W, Digilio G, Keupp J, Langereis S, Lanzardo S, Prestigio S, Steinbach O, Terreno E, Uggeri F, Aime S. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: in vivo studies in mice at 7T. Magn. Reson. Med. 2011; 65(1): 202-211.
12. 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br. J. Cancer, 1998; 78(5): 606-611.
13. Jakobsen I, Lyng H, Kaalhus O, Rofstad EK. MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume. Magn. Reson. Imaging, 1995; 13(5): 693-700.
14. Vincensini D, Dedieu V, Eliat PA, Vincent C, Bailly C, de Certaines J, Joffre F. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry. Magn. Reson. Imaging, 2007; 25(3): 293-302.
15. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am. J. Physiol. 1994; 267(1 Pt 1): C195-C203.
16. Mason RP. Transmembrane pH gradients in vivo: measurements using fluorinated vitamin B6 derivatives. Curr. Med. Chem. 1999; 6(6): 481-499.
17. 1H NMR probes for intracellular pH. Bioorg. Med. Chem. Lett. 1992; 2(12): 1717-1722.
18. 1H MRSI. Magn. Reson. Med. 1999; 41(4): 743-750.
19. Bhujwalla ZM, Artemov D, Ballesteros P, Cerdan S, Gillies RJ, Solaiyappan M. Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed. 2002; 15(2): 114-119.
20. 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res. 2001; 61(17): 6524-6531.
21. 89Y complexes as pH sensitive NMR probes. J. Am. Chem. Soc. 2010; 132(6): 1784-1785.
22. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn. Reson. Med. 2000; 44(5): 799-802.
23. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 2003; 9(8): 1085-1090.
24. Zhang S, Merritt M, Woessner DE, Lenkinski RE, Sherry AD. PARACEST agents: modulating MRI contrast via water proton exchange. Acc. Chem. Res. 2003; 36(10): 783-790.
25. Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno E. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn. Reson. Med. 2002; 47(4): 639-648.
26. Raghunand N, Zhang S, Sherry AD, Gillies RJ. In vivo magnetic resonance imaging of tissue pH using a novel pH-sensitive contrast agent, GdDOTA-4AmP. Acad. Radiol. 2002; 9 (Suppl 2): S481-S483.
27. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ. Renal and systemic pH imaging by contrast-enhanced MRI. Magn. Reson. Med. 2003; 49(2): 249-257.
28. Zhang J, Martinez GV, Garcia-Martin ML, Woods M, Sherry D, Gillies RJ. High spatio-temporal resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Int. Soc. Magn. Reson. Med. 2008; 17: 370.
29. 2. J. Cereb. Blood Flow Metab. 1987; 7(6): 709-719.
30. 2 and positron emission tomography. J. Cereb. Blood Flow Metab. 1984; 4(1): 8-16.
31. Vavere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res. 2009; 69(10): 4510-4516.
32. Provent P, Benito M, Hiba B, Farion R, Lopez-Larrubia P, Ballesteros P, Remy C, Segebarth C, Cerdan S, Coles JA, Garcia-Martin ML. Serial invivo spectroscopic nuclear magnetic resonance imaging of lactate and extracellular pH in rat gliomas shows redistribution of protons away from sites of glycolysis. Cancer Res. 2007; 67(16): 7638-7645.
33. 13C-labelled bicarbonate. Nature, 2008; 453(7197): 940-943.
34. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc. Natl. Acad. Sci. U.S.A., 2003; 100(18): 10158-10163.
35. Wilson DM, Keshari KR, Larson PE, Chen AP, Hu S, Van Criekinge M, Bok R, Nelson SJ, Macdonald JM, Vigneron DB, Kurhanewicz J. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities invivo. J. Magn. Reson. 2010; 205(1): 141-147.
36. 13C magnetic resonance imaging. Prog. NMR Spectrosc. 2009; 55(4): 285-295.
37. 13C-labeled glutamine. Magn. Reson. Med. 2008; 60(2): 253-257.
38. Melnikov P, Zanoni LZ. Clinical effects of cesium intake. Biol. Trace Elem. Res. 2010; 135(1-3): 1-9.
39. Hu DE, Beauregard DA, Bearchell MC, Thomsen LL, Brindle KM. Early detection of tumour immune-rejection using magnetic resonance imaging. Br. J. Cancer, 2003; 88(7): 1135-1142.
40. Schroeder MA, Cochlin LE, Heather LC, Clarke K, Radda GK, Tyler DJ. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc. Natl. Acad. Sci. U.S.A., 2008; 105(33): 12051-12056.
41. Blank PS, Silverman HS, Chung OY, Hogue BA, Stern MD, Hansford RG, Lakatta EG, Capogrossi MC. Cytosolic pH measurements in single cardiac myocytes using carboxy-seminaphthorhodafluor-1. Am. J. Physiol. 1992; 263(1 Pt 2): H276-H284.
42. Vandenberg JI, Carter ND, Bethell HW, Nogradi A, Ridderstrale Y, Metcalfe JC, Grace AA. Carbonic anhydrase and cardiac pH regulation. Am. J. Physiol. 1996; 271(6 Pt 1): C1838-C1846.
43. Leem CH, Vaughan-Jones RD. Out-of-equilibrium pH transients in the guinea-pig ventricular myocyte. J. Physiol. 1998; 509 (Pt 2): 471-485.
44. Gadian DG. NMR and its Applications to Living Systems. Oxford University Press: Oxford; 1995.
45. 31P NMR measurements of myocardial pH in vivo. Biochem. Biophys. Res. Commun. 1988; 151(1): 70-77.
46. 31P magnetic resonance spectroscopy study. Cardiovasc. Res. 2010; 86(1): 82-91.
47. Kernohan JC. The pH-activity curve of bovine carbonic anhydrase and its relationship to the inhibition of the enzyme by anions. Biochim. Biophys. Acta, 1965; 96: 304-317.
48. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 1971; 246(8): 2561-2573.
49. Brindle KM. NMR methods for measuring enzyme kinetics in vivo. Prog. NMR Spectrosc. 1988; 20: 257-293.
50. 13C magnetic resonance imaging and spectroscopy. Nat. Med. 2007; 13(11): 1382-1387.
51. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts. N. Engl. J. Med. 1998; 338(1): 26-34.
52. British National Formulary, Vol. 60. British Medical Association and Royal Pharmaceutical Society of Great Britain: London; 2010. [accessed 11 January 2010].
53. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM. MRI of the tumor microenvironment. J. Magn. Reson. Imaging, 2002; 16(4): 430-450.
54. Raghunand N, He X, van Sluis R, Mahoney B, Baggett B, Taylor CW, Paine-Murrieta G, Roe D, Bhujwalla ZM, Gillies RJ. Enhancement of chemotherapy by manipulation of tumour pH. Br. J. Cancer, 1999; 80(7): 1005-1011.
55. Raghunand N, Mahoney B, van Sluis R, Baggett B, Gillies RJ. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia, 2001; 3(3): 227-235.